Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34Combined Modality TherapyLeukapheresisHematologic NeoplasmsStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalCyclophosphamideMultiple MyelomaGraft vs Host DiseaseStem CellsMyeloablative AgonistsHematopoietic Stem CellsTreatment OutcomeBusulfanGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisCord Blood Stem Cell TransplantationIfosfamideSalvage TherapyHematopoiesisDisease-Free SurvivalVincristineAmyloidosisCytarabineHodgkin DiseaseTransplantation ChimeraNeoplasmsTissue DonorsSurvival RateRetrospective StudiesSurvival AnalysisDoxorubicinWhole-Body IrradiationTime FactorsHistocompatibility TestingHistocompatibilityInfectionLymphoma, T-CellPlatelet CountCarboplatinBlood Cell CountPOEMS SyndromeTransplantation, IsogeneicLeukemia, Myeloid, AcutePrednisoneImmunosuppressive AgentsLeukemiaFollow-Up StudiesDexamethasoneVidarabineRecombinant ProteinsProspective StudiesLymphomaBone Marrow PurgingBlood CellsEmbryonic Stem CellsCytomegalovirus InfectionsFatal OutcomeFeasibility StudiesGraft vs Leukemia EffectMyelodysplastic SyndromesAdult Stem CellsImmunophenotypingMesenchymal Stem Cell TransplantationLymphocyte DepletionHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticBreast NeoplasmsPrognosisBlood Transfusion, AutologousT-LymphocytesHLA AntigensLiver TransplantationBone MarrowFlow CytometryPrecursor Cell Lymphoblastic Leukemia-LymphomaBlood DonorsLeukocytes, MononuclearCell SeparationOpportunistic InfectionsPluripotent Stem CellsHistiocytosis, Non-Langerhans-Cell